搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
1 天
2024 CSCO丨真实世界数据证实,曲拉西利可安全、有效改善 ES-SCLC 患者 ...
目前,化疗仍是 ES-SCLC 治疗的重要组成部分,但化疗导致的骨髓抑制(CIM)会严重影响患者用药依从性和预后,且现有的干预措施主要为对症治疗,存在局限性。为探索在真实世界环境中,预防性使用曲拉西利对我国 ES-SCLC ...
1 天
鼻毛这种好东西,千万不要拔啊啊啊啊啊啊!
一根黝黑粗壮的鼻毛无声地从鼻腔里窜出来,对面的Ta,很难不一直盯着它看。即使人再好看,眼睛,也只能聚焦在这根昂首挺胸的毛发上。很多人会选择拔掉或剪掉这些毛,以绝后患。可能是用剪的、也可能硬拔的,甚至还有用蜜蜡去除的......那我们到底该拿这“讨厌” ...
News Medical on MSN
2 天
Study: MMR vaccine remains the most effective measure to prevent measles infection
Most measles cases in England are among unvaccinated individuals. But, between 2011 and 2019, the proportion of measles cases ...
Too Old to Operate
2 天
Potential of NMDAR NR1 mRNA as a Clinical Marker for Insomnia Disorder
The following is a summary of “Elevated peripheral glutamate and upregulated expression of NMDA receptor NR1 subunit in ...
Too Old to Operate
3 天
Lesion Diameter as a Prognostic Factor for Treatment Failure in Bowen’s Disease
The following is a summary of “Prognostic factors for treatment failure of photodynamic therapy and 5-fluorouracil in Bowen’s ...
BioSpace
3 天
Study Casts Doubt on Benefit of Anti-CD20 Therapies in Multiple Sclerosis
New research has found that MS patients treated with anti-CD20 antibodies, such as Roche’s Ocrevus, do not experience ...
3 天
MMR vaccine remains best protection against measles, but study suggests level of protection ...
Most measles cases in England are among unvaccinated individuals. But, between 2011 and 2019, the proportion of measles cases ...
ophthalmologytimes
18 天
Retina Society 2024: Observational, retrospective US-based cohort study on newly diagnosed ...
Theodore Leng, MD, MS, sat down with David Hutton of Ophthalmology Times to discuss his presentation on Progression of Newly ...
Medscape
6 天
Study Indicates Who May Benefit Most From GA Treatment
A real-world study of pegcetacoplan for treatment of geographic atrophy showed significantly better outcomes than the pivotal clinical trials in patients who had symptomatic vision loss.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈